#72 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians need current evidence on cannabis efficacy for women-specific conditions like sexual dysfunction and reproductive health concerns to provide informed counseling and evidence-based treatment recommendations. As preliminary clinical data emerges supporting cannabis use for female sexual function, providers should understand these findings to discuss potential benefits and risks with patients seeking alternatives to conventional therapies. Women represent a growing demographic of cannabis patients, making sex and gender-specific safety and efficacy data essential for clinical decision-making.
A 2024 preliminary clinical trial has demonstrated significant improvements in sexual function and orgasm outcomes among women using medical cannabis, highlighting an emerging area of therapeutic potential that has historically received limited research attention. This finding is particularly relevant given that female patients represent a growing proportion of medical cannabis users, yet their specific health needs and treatment efficacy have been substantially underrepresented in the clinical literature. The focus on women’s health outcomes in cannabis research reflects a broader shift toward understanding sex-specific and gender-specific responses to cannabinoids, which may differ meaningfully from the predominantly male-centered research base that has informed clinical practice to date. For clinicians caring for women, these emerging data suggest that cannabis may warrant consideration as part of a comprehensive treatment approach for sexual dysfunction, though larger and more rigorous trials are needed before firm clinical recommendations can be made. As women continue to drive market demand and research priorities in medical cannabis, clinicians should remain informed about sex-specific efficacy and safety profiles to provide evidence-based counseling to their female patients.
“We’re finally seeing rigorous data on cannabis and sexual function in women, and what emerges is that cannabinoids can meaningfully improve arousal and orgasmic response in a subset of patients, which matters because sexual dysfunction is profoundly undertreated in primary care and women often have nowhere else to turn.”
🏥 While emerging evidence suggesting cannabis may improve sexual function in women warrants attention, clinicians should approach these findings with appropriate caution given the preliminary nature of current research and substantial gaps in long-term safety and efficacy data specific to women’s health outcomes. The mechanisms underlying any potential benefits remain poorly understood, and individual responses vary considerably based on cannabis formulation, dose, route of administration, and patient-specific factors including concurrent medications and underlying health conditions. Important confounders include the placebo effect, selection bias in early trials, and the absence of standardized dosing protocols or quality control in many cannabis products currently available to patients. When counseling women about cannabis use for sexual health concerns, providers should acknowledge the limited but growing evidence base while emphasizing the need for rigorous, large-scale randomized controlled trials before drawing clinical conclusions. In practice, this means discussing cannabis as one of several potential approaches to sexual dysfunction while prioritizing assessment for underlying medical and psychological
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: